The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1336
April 19, 2010
View Complete Issue         Table of Contents 2019 
L-Methylfolate (Deplin) for Depression and Schizophrenia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
L-Methylfolate (Deplin) for Depression and Schizophrenia
April 19, 2010 (Issue: 1336)
L-methylfolate (Deplin — Pamlab) is a “medical food” marketed for adjunctive use in depression or schizophrenia in patients with suboptimal folate levels. It is available only by prescription.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: L-Methylfolate (Deplin) for Depression and Schizophrenia
Article code: 1336d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.